Medtronic plc logo
Medtronic plc (MDT)
Compare

Medtronic plc (MDT) Return on Assets (ROA): 5.25%

Is Medtronic plc’s return on assets (ROA) high or low?

Medtronic plc's return on assets (ROA) of 5.25% is 39% above its 5-year average of 3.79%, near the high end of its 5-year range (0.00%–5.54%).

The return on assets (ROA) for Medtronic plc (MDT) is 5.25% as of Wednesday, June 10, 2026. It is above its 12-month average by 106.29% (2.54%).

MDT Return on Assets (ROA) Chart

MDT Return on Assets (ROA)
0.00%-100.00% 1Y
Zoom

MDT Average Return on Assets (ROA) Chart

MDT Current vs Average Return on Assets (ROA) Chart

MDT Return on Assets (ROA) Metrics

RETURN ON ASSETS (ROA)

5.25%

RETURN ON ASSETS (ROA) AVG TTM

2.54%

RETURN ON ASSETS (ROA) AVG 3Y

3.33%

RETURN ON ASSETS (ROA) AVG 5Y

3.79%

RETURN ON ASSETS (ROA) AVG 10Y

4.01%

RETURN ON ASSETS (ROA) AVG 15Y

5.36%

RETURN ON ASSETS (ROA) AVG 20Y

6.83%

CURRENT VS TTM AVG

+106.29%

CURRENT VS 3Y AVG

+57.78%

CURRENT VS 5Y AVG

+38.64%

CURRENT VS 10Y AVG

+30.80%

CURRENT VS 15Y AVG

-2.11%

CURRENT VS 20Y AVG

-23.10%

MDT Competitors' Return on Assets (ROA)

NAMEMARKET CAPRETURN ON ASSETS (ROA)TTM3Y5Y
Medtronic plc (MDT)5.25%2.54%3.33%3.79%
Vertex Pharmaceuticals Incorporated (VRTX)$110.77B16.38%6.37%11.74%14.58%
Bristol-Myers Squibb Company (BMY)$114.14B8.41%-0.92%3.28%1.99%
Elevance Health Inc. (ELV)$87.43B4.17%4.89%5.25%5.41%
CVS Health Corporation (CVS)$125.16B1.16%1.25%1.93%2.38%
Cigna Corporation (CI)$78.25B4.10%2.99%3.50%3.82%
Danaher Corporation (DHR)$130.25B4.42%4.68%5.89%6.01%
Regeneron Pharmaceuticals, Inc. (REGN)$62.59B10.82%11.40%12.40%16.97%
Pfizer Inc. (PFE)$146.36B3.61%3.75%6.08%7.08%
Intuitive Surgical, Inc. (ISRG)$146.44B14.81%13.09%12.00%11.68%

Asset Efficiency

ROA

5.3%

ROE

9.8%

Medtronic plc Return on Assets (ROA) Formula & Definition

ROA = Net Income / Total Assets

Return on assets measures how efficiently a company generates profit from its total assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Medtronic plc Return on Assets (ROA) FAQ

What is the return on assets (ROA) for Medtronic plc (MDT)?
The return on assets (ROA) for MDT stock is 5.25%.
Is Medtronic plc's return on assets (ROA) high or low?
Medtronic plc's return on assets (ROA) of 5.25% is 39% above its 5-year average of 3.79%, near the high end of its 5-year range (0.00%–5.54%).
What is the TTM average return on assets (ROA) for Medtronic plc (MDT)?
The TTM average return on assets (ROA) for MDT stock is 2.54%.
What is the 3Y average return on assets (ROA) for Medtronic plc (MDT)?
The 3Y average return on assets (ROA) for MDT stock is 3.33%.
What is the 5Y average return on assets (ROA) for Medtronic plc (MDT)?
The 5Y average return on assets (ROA) for MDT stock is 3.79%.
What is the 10Y average return on assets (ROA) for Medtronic plc (MDT)?
The 10Y average return on assets (ROA) for MDT stock is 4.01%.
What is the 15Y average return on assets (ROA) for Medtronic plc (MDT)?
The 15Y average return on assets (ROA) for MDT stock is 5.36%.
What is the 20Y average return on assets (ROA) for Medtronic plc (MDT)?
The 20Y average return on assets (ROA) for MDT stock is 6.83%.

Medtronic plc Return on Assets (ROA) History

DATERETURN ON ASSETS (ROA)
2026-04-240.00%
2025-04-255.09%
2024-04-264.09%
2023-04-284.13%
2022-04-295.54%
2021-04-303.87%
2020-04-245.28%
2019-04-305.16%
2018-04-303.40%
2017-04-304.04%
2016-04-303.55%
2015-04-302.51%
2014-04-308.08%
2013-04-309.96%
2012-04-3010.93%
2011-04-3010.18%
2010-04-3011.03%
2009-04-309.17%
2008-04-3010.05%
2007-04-3014.36%
2006-04-3012.95%
2005-04-3010.86%
2004-04-3013.89%
2003-04-3012.98%
2002-04-309.02%
2001-04-3014.86%
2000-04-3019.38%
1999-04-309.62%
1998-04-3021.43%
1997-04-3024.21%

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha